Daiken Medical Co., Ltd.

Tokyo Stock Exchange 7775.T

Daiken Medical Co., Ltd. Gross Profit Margin for the year ending March 31, 2024: 40.84%

Daiken Medical Co., Ltd. Gross Profit Margin is 40.84% for the year ending March 31, 2024, a 5.71% change year over year. Gross Profit Ratio is the ratio of gross profit to net sales, indicating the percentage of revenue that exceeds the cost of goods sold and reflects the efficiency of a company in managing its production or procurement and sales.
  • Daiken Medical Co., Ltd. Gross Profit Margin for the year ending March 31, 2023 was 38.64%, a -10.43% change year over year.
  • Daiken Medical Co., Ltd. Gross Profit Margin for the year ending March 31, 2022 was 43.14%, a 0.96% change year over year.
  • Daiken Medical Co., Ltd. Gross Profit Margin for the year ending March 31, 2021 was 42.73%, a -2.46% change year over year.
  • Daiken Medical Co., Ltd. Gross Profit Margin for the year ending March 31, 2020 was 43.81%, a -6.48% change year over year.
Key data
Date Gross Profit Margin Operating Income Margin EBT Margin Net Income Margin
Market news
Tokyo Stock Exchange: 7775.T

Daiken Medical Co., Ltd.

CEO Mr. Keiichi Yamada
IPO Date March 12, 2009
Location Japan
Headquarters 2-6-2, Ayumino
Employees 175
Sector Health Care
Industries
Medical Instruments Pharmaceuticals
Description

Daiken Medical Co., Ltd. manufactures and distributes medical devices and equipment in Japan and internationally. The company offers syringe pumps, disposable infusion pumps, portable disposable infusers, endobronchial blocker tubes, suction containers, connecting tubes, suction tips, medical hand washing machines, disposable medical towels, sterilize mats, and wet disinfectant mats. It also trades in medical equipment. The company sells its products under the COOPDECH brand. Daiken Medical Co., Ltd. was incorporated in 1968 and is headquartered in Izumi, Japan.

StockViz Staff

January 15, 2025

Any question? Send us an email